P

Inventor

MACLEOD CALUM

GB30 patents
⚠️ This page may combine multiple inventors who share the name “MACLEOD CALUM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JANSSEN PHARMACEUTICA NV

13 patents
US9643964B2May 9, 2017

3-(2-aminopyrimidin-4-yl)-5-(3-hydroxypropynyl)-1H-pyrrolo[2,3-C]pyridine derivatives as NIK inhibitors for the treatment of cancer

JANSSEN PHARMACEUTICA NV9 citations83
US11236084B2Feb 1, 2022

Substituted azaindoline derivatives as NIK inhibitors

JANSSEN PHARMACEUTICA NV0 citations50
US11186589B2Nov 30, 2021

Cyanoindoline derivatives as NIK inhibitors

JANSSEN PHARMACEUTICA NV0 citations50
US11180487B2Nov 23, 2021

Substituted cyanoindoline derivatives as NIK inhibitors

JANSSEN PHARMACEUTICA NV0 citations50
US11136311B2Oct 5, 2021

Heteroaromatic derivatives as NIK inhibitors

JANSSEN PHARMACEUTICA NV0 citations50
US11001569B2May 11, 2021

6-membered heteroaromatic substituted cyanoindoline derivatives as NIK inhibitors

JANSSEN PHARMACEUTICA NV0 citations50
US10822342B2Nov 3, 2020

Pyrazolopyrimidine derivatives as NIK inhibitors

JANSSEN PHARMACEUTICA NV0 citations50
US10221180B2Mar 5, 2019

Pyrazolopyrimidine derivatives as NIK inhibitors

JANSSEN PHARMACEUTICA NV0 citations50
US10005776B2Jun 26, 2018

Compounds as NIK inhibitors

JANSSEN PHARMACEUTICA NV0 citations40
US10005773B2Jun 26, 2018

1-(4-pyrimidinyl)-1H-pyrrolo[3,2-c]pyridine derivatives as NIK inhibitors

JANSSEN PHARMACEUTICA NV0 citations40
US10323045B2Jun 18, 2019

Thienopyrimidine derivatives as NIK inhibitors

JANSSEN PHARMACEUTICA NV0 citations39
US9981963B2May 29, 2018

3-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-c]pyridine derivatives as NIK inhibitors

JANSSEN PHARMACEUTICA NV0 citations39
US9981962B2May 29, 2018

Pyrazole derivatives as NIK inhibitors

JANSSEN PHARMACEUTICA NV0 citations38

GENENTECH INC

9 patents

ENYO PHARMA

4 patents

HOFFMANN LA ROCHE

1 patent

CHEN HUIFEN

1 patent

BLENCH TOBY JONATHAN

1 patent

BELL MARK PETER

1 patent